Post Market Clinical Follow-Up of Plasmafit® Cup

Twelve months follow-up of implant survival and clinical and radiological follow-up of Plasmafit® Cup.

Inclusion Criteria:

• Minimum age 18 years
• Indication for cementless total hip arthroplasty
• Patient consent for study participation
• Physical and mental willingness to participate at clinical and radiological follow-up

Exclusion Criteria:

• Patient not available for follow-up
• Increased anesthetics risks according to the "American Society of Anesthesiology": ASA IV
• Tumor
• Alcohol or drug abuse
• Permanent cortisone therapy
• Clinically relevant infection
• Pregnancy or planned pregnancy
• Prior interventions like osteotomy, fracture treatment or prior THA at the concerned hip
• Acute fracture at the concerned hip
• Patients needing a cemented hip arthroplasty